Effects of adenosine receptor agents on the expression of morphine withdrawal in mice

European Journal of Pharmacology

Volumn 369, Issue 1, 1999, Pages 17-22

  Zarrindast, Mohammad Reza ^a   Naghipour, Bahram ^a   Roushan Zamir, Farshad ^a   Shafaghi, Bijan ^a  

^a NONE

Author keywords

Adenosine; Diarrhea; Jumping; Morphine; Mouse; Naloxone

Indexed keywords

3,7 DIMETHYL 1 PROPARGYLXANTHINE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE 5' (N CYCLOPROPYLCARBOXAMIDE); ADENOSINE A1 RECEPTOR ANTAGONIST; ADENOSINE RECEPTOR BLOCKING AGENT; ADENOSINE RECEPTOR STIMULATING AGENT; CYCLOHEXYLADENOSINE; MORPHINE; NALOXONE; PHENYLISOPROPYLADENOSINE;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DIARRHEA; DRUG EFFECT; DRUG WITHDRAWAL; INTRAPERITONEAL DRUG ADMINISTRATION; JUMPING; MALE; MORPHINE ADDICTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; WITHDRAWAL SYNDROME;

ADENOSINE; ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; DIARRHEA; MALE; MICE; MICE, INBRED STRAINS; MORPHINE; MORPHINE DEPENDENCE; NALOXONE; NARCOTIC ANTAGONISTS; NARCOTICS; RECEPTORS, PURINERGIC P1; SUBSTANCE WITHDRAWAL SYNDROME; THEOBROMINE; XANTHINES;

EID: 0033065301     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00021-7     Document Type: Article

References (29)

1. 6-(R-phenylisopropyl)-adenosine (PIA) and caffeine on nociception and morphine-induced analgesia, tolerance and dependence in mice. Eur. J. Pharmacol. 112:1985;171-179.
2. Bilsky E.J., Montegut M.J., Delong C.L., Reid L.D. Opioidergic modulation of cocaine conditioned place preference. Life Sci. 50:1992;85-90.
3. Bonci A., Williams J.T. A common mechanism mediates long-term changes in synaptic transmission after chronic cocaine and morphine. Neuron. 16:1996;631-639.
4. Bundege J.M., Dunwiddie T.V. Role of adenosine as a modulator of synaptic activity in the CNS. Advances in Pharmacology. 39:1997;353-391.
5. Daly J.W. Adenosine receptors: targets for future drugs. J. Med. Chem. 25:1982;197-207.
6. Dalziel H.H., Westfall D.P. Receptors for adenine nucleotides and nucleosides: subclassification, distribution and molecular characterization. Pharmacol. Rev. 46:1994;449-465.
7. De Lander G.E., Kiel J. Antinociception induced by intrathecal coadministration of selective adenosine receptor and selective opioid receptor agonists in mice. J. Pharmacol. Exp. Ther. 268:1994;943-951.
8. Dionyssopoulos T., Hope W., Coupar I.M. Effect of adenosine analogues on the expression of opiate withdrawal in rats. Pharmacol. Biochem. Behav. 42:1992;201-206.
9. Dunwiddie T.V. The physiological role of adenosine in the central nervous system. Int. Rev. Neurobiol. 27:1985;63-139.
10. Fredholm B.B., Abbracchio M.P., Burnstock G., Daly J.W., Harden T.K., Jacobson K.A., Leff P., Williams M. Nomenclature and classification of purinoceptors. Pharmacol. Rev. 64:1994;143-156.
11. Harms H.H., Wardeh G., Mulder A.H. Effects of adenosine on depolarization induced release of various radio-labelled neurotransmitters from slices of rat corpus striatum. Neuropharmacology. 18:1979;577-580.
12. Jacobson K.A., van Galen P.J.M., Williams M. Adenosine receptors: pharmacology, structure-activity relationships and therapeutic potential. J. Med. Chem. 35:1992;407-422.
13. Kaplan G.B., Sears M.T. Adenosine receptor agonists attenuate and adenosine receptor antagonists exacerbate opiate withdrawal signs. Psychopharmacology. 123:1996;64-70.
14. 2b receptors coupled to distinct interactive signalling pathway in intestinal muscle cells. J. Pharmacol. Exp. Ther. 274:1995;300-306.
15. Myers S., Pugsley T.A. Decrease in rat striatal dopamine synthesis and metabolism in vivo by metabolically stable adenosine receptor agonists. Brain Res. 375:1986;193-197.
16. Olah M.E., Stiles G.L. Adenosine receptor subtypes: characterization and therapeutic regulation. Annu. Rev. Pharmacol. Toxicol. 35:1995;581-606.
17. Porreca F., Burks T.F. The spinal cord as a site of opioid effects on gastrointestinal transit in the mouse. J. Pharmacol. Exp. Ther. 227:1983;22-27.
18. Sabetkasai M., Zarrindast M.R. Antinociception: interaction between adenosine and GABA systems. Arch. Int. Pharmacodyn. 322:1993;14-22.
19. Salem A., Hope W. Effect of adenosine receptor agonists and antagonists on the expression of opiate withdrawal in rats. Pharmacol. Biochem. Behav. 57:1997;671-679.
20. Sawynok J., Sweeney M.I., White T.D. Adenosine release may mediate spinal analgesia by morphine. Trends Pharmacol. Sci. 10:1989;186-189.
21. Seale T., Abla K.A., Shamim M.T., Carney J.M., Daly J.W. 3,7-Dimethyl-1-1-propargylxanthine: a potent and selective in vivo antagonist of adenosine analogs. Life Sci. 43:1988;1671-1684.
22. 1 receptors in rats. Eur. J. Pharmacol. 278:1995;233-237.
23. Tucker J.F., Plant N.T., von-Uexkull A., Collier H.O. Inhibition by adenosine analogs of opiate withdrawal effects. NIDA Res. Monogr. 49:1984;85-91.
24. Weis O.F., Sriwatanakul K., Alloza J.L., Weintraub M., Lasagna L. Attitudes of patients, house staff, and nurses toward postoperative analgesic care. Anesth. Analg. 62:1983;70-74.
25. Yarbrough G.C., McGuffin-Clineschmidt J.C. In vivo behavioural assessment of central nervous system purinergic receptors. Eur. J. Pharmacol. 76:1981;137-144.
26. Zarrindast, M.R., Farzin, D., 1996. Nicotine attenuates naloxone-induced jumping behaviour in morphine-dependent mice, 298, 1-6.
27. Zarrindast M.R., Sabetkasai M., Khakpour Sh. Effects of drug active at adenosine receptors on stress-induced analgesia in mice. Arch. Int. Pharmacodyn. 325:1993;51-60.
28. Zarrindast M.R., Sharifzadeh M., Sadeghi A.I. Theophylline-induced grooming: possible indirect dopaminergic mechanism. Eur. J. Pharmacol. 306:1996;1-4.
29. Zarrindast M.R., Iraie F., Heidari M.R., Mohagheghi-Badi M. Effect of adenosine receptor agonists and antagonists on morphine-induced catalepsy in mice. Eur. J. Pharmacol. 338:1997;11-16.